江汉大学学报(自然科学版) ›› 2024, Vol. 52 ›› Issue (6): 88-96.doi: 10.16389/j.cnki.cn42-1737/n.2024.06.010

• 医学 • 上一篇    

儿童抗N-甲基-D-天冬氨酸受体脑炎继发癫痫的 相关影响因素分析

齐 乐1,孙 丹*2   

  1. 1. 江汉大学 医学部,湖北 武汉 430056;2. 武汉儿童医院 神经内科,湖北 武汉 430016
  • 发布日期:2024-12-25
  • 通讯作者: 孙 丹
  • 作者简介:齐 乐(1995—),女,硕士生,研究方向:儿童自身免疫性脑炎。
  • 基金资助:
    湖北省科技计划立项项目(2022DCC020)

Related Influencing Factors Analysis of Epilepsy Secondary to Anti-N-methyl-D-aspartate Receptor Encephalitis in Children

QI Le,SUN Dan   

  1. 1. School of Medicine,Jianghan University,Wuhan 430056,Hubei,China;2. Department of Neurology,Wuhan Children′s Hospital,Wuhan 430016,Hubei,China
  • Published:2024-12-25
  • Contact: SUN Dan

摘要: 目 的 目前抗N-甲基-D-天冬氨酸受体(N-methyl-D-aspartate receptor, NMDAR)脑炎患儿恢复期继发癫痫的风险低,相关研究较少,大部分临床医生对其认识不足。 对继发癫痫和非继发癫痫的抗NMDAR脑炎患儿进行对比研究,以提高临床医生对抗NMDAR 脑炎及其继发癫痫的临床特征及相关影响因素的认识。方 法 回顾性分析2015年1月至2022 年1月就诊于武汉儿童医院神经内科的50例确诊抗NMDAR脑炎患儿的临床资料,根据最后随 访时患儿是否继发癫痫分为脑炎后癫痫组(PE组)和脑炎后非继发癫痫组(NO-PE组),采用泊 松回归分析进行统计。结 果 脑炎后癫痫发生率为8%(4/50)。50例患儿男女比为0.61∶1,继 发癫痫患儿男女比是1∶3。抗NMDAR脑炎临床症状表现多样,最常见临床症状之一的癫痫发 作占86%(43/50),其中以癫痫发作为起病的占64%(32/50)。继发癫痫患儿中有75%(3/4)也 是以癫痫发作作为首发症状,同时更容易遗留运动障碍(50%(2/4))和学习能力下降(75%(3/4))。 治疗上,大部分脑炎患儿给予免疫治疗,急性期有74%(37/50)给予抗癫痫药物治疗。PE组头颅 影像学示皮质下受累(75%(3/4)比13%(6/46))、累及基底节区(50%(2/4)比0(0/46))及脑电 图提示存在δ刷(50%(2/4)比 8.7%(4/46))与 NO-PE 组比较差异均有统计学意义(P < 0. 05)。结 论 抗NMDAR脑炎患儿临床症状表现多样,继发癫痫发生率低,进展为脑炎后癫 痫,若及时添加抗癫痫药物可控制发作;头颅影像学示皮质下受累、基底节区受累及脑电图提示 存在δ刷的患儿更易继发癫痫。

关键词: 自身免疫性脑炎, 脑炎后癫痫, 儿童

Abstract: Objective The current low risk of secondary epilepsy in children recovering from N-methyl-D-aspartate receptor (NMDAR) resistant encephalitis is poorly studied and under-recognized by most clinicians. A comparative study of children with anti-NMDAR encephalitis secondary to epilepsy and non-secondary to epilepsy was conducted to improve clinicians′ understanding of the clinical features and associated factors influencing anti NMDAR encephalitis and its secondary epilepsy. Methods A retrospective analysis was conducted on the clinical data of 50 children with confirmed anti-NMDAR encephalitis who visited the neurology department of Wuhan Children′s Hospital from January 2015 to January 2022. Based on whether the children had secondary epilepsy at the final follow-up,they were divided into the post-encephalitis epilepsy group (PE group) and the post encephalitis non-secondary epilepsy group(NO-PE group). Poisson regression analysis was used for statistics. Results The incidence of post-encephalitis epilepsy was 8%(4/50). The male-to-female ratio of 50 children was 0. 61∶1. The male-to-female ratio of children with secondary epilepsy was 1∶3. The clinical manifestations of anti-NMDAR encephalitis were diverse,with epilepsy being one of the most common clinical symptoms,accounting for 86%(43/50),of which 64%(32/50)were initiated by epilepsy. Among children with secondary epilepsy,75%(3/4)also had seizures as the first symptom and were more likely to have motor disorders left(50%(2/4))and decreased learning ability left(75%(3/4)). In terms of treatment,most children with encephalitis received immunotherapy,and 74% (37/50)of them were treated with antiepileptic drugs in the acute phase. The head imaging showed there was a statistically significant difference(P < 0. 05)between the PE group and the NO-PE group in subcortical involvement(75%(3/4)vs. 13%(6/46)),involvement of the basal ganglia area(50%(2/4)vs. 0%(0/46)),and electroencephalography showing the presence δ brush(50%(2/4))vs.(8. 7%(4/46)). Conclusion The clinical symptoms of children with anti-NMDAR encephalitis are diverse,and the incidence of secondary epilepsy is low. Antiepileptic drugs can promptly control seizures after progression to post encephalitis epilepsy,the children with head imaging showing subcortical involvement,basal ganglia area,and electroencephalogram suggesting the presence δ brush are more likely to develop secondary epilepsy.

Key words: autoimmune encephalitis, postencephalitic epilepsy, children

中图分类号: